References
- Lebel M., Kingma I., Grose J. H., Langlois S. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients. Am J Hypertens 1994; 9: 545–551
- Buckner F. S., Eschbach J. W., Haley N. R., Davidson R. C., Adamson J. W. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertension 1990; 3: 947–955
- Abraham P. A., Macres M. G. Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin. J Am Soc Nephrol 1991; 2: 927–936
- Canadian Erythropoietin Study Group. Effect of recombinant human erythropoietin therapy on blood pressure in hemodialysis patients. Am J Nephrol 1991; 11: 23–26.
- Ludwig H., Fritz E., Kotzmann H., Höcker P., Gesslinger M., Barnes U. Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 1990; 322: 1693–1699
- Pincus T., Olsen N. J., Russell J., Wolfe F., Harris E. R., Schnitzer T. J., Boccagno J. H., Krantz S. B. Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 1990; 89: 161–168
- Fischl M., Galpin J. E., Levine J. D., Groopman J. E., Henry D. H., Kennedy P., Miles S., Robbins W., Starrett B., Zalusky R., Abels R. I., Tsai H. C., Rudnick S. A. Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 1990; 322: 1488–1493
- Berglund B., Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. J Intern Med 1991; 229: 125–130
- Nephrol Dial Transplant 1993; 8: 621–625, on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin
- Hori K., Onoyama K., Iseki K., Fujimi S., Fujishima M. Hemodynamic and volume changes by recombinant human erythropoietin in the treatment of anemic hemodialysis patients. Clin Nephrol 1990; 33: 293–298
- Lebel M., Grose J. H., Kingma I., Langlois S. Plasma endothelin of subcutaneous erythropoietin replacement therapy. Clin Exper Hypertens (A) 1994; 16: 565–575
- Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572–575
- Anagnostou A., Liu Z., Steiner M., Chin K., Lee E. S., Kessimian N., Noguchi C. T. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994; 91: 3974–3978
- Carlini P. G., Dusso A. S., Obialo C. I., Alvarez U. M., Rothstein M. Recombinant human erythropoietin increases endothelin-1 release by endothelial cells. Kidney Int 1993; 43: 1010–1014
- Heidenreich S., Rahn K. H., Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int 1991; 39: 259–265